caa a22 4500 388094796 CHVBK 20180307125301.0 cr unu---uuuuu 161130e199910 xx s 000 0 eng 10.1017/S1092852900012347 doi S1092852900012347 pii (NATIONALLICENCE)cambridge-10.1017/S1092852900012347 Treatment Issues During Pregnancy and Lactation [Elektronische Daten] The lifetime incidence of mood disorders is twice as great in women compared with men, with the highest risk occurring during the childbearing years. The management of mental illness during pregnancy and lactation is a particularly complex clinical situation. The cornerstone of such a clinical decision is a completion of an assessment of the risks of the illness vs the risks of treatment. The following article reviews the factors influencing infant outcome and outlines the essential elements of the process of determining risk for the use of psychotropics in women during pregnancy and lactation. As the available data rapidly change, the facets of the risk benefit assessment are consistent and often the issue of specific medication is decided by prior history and exposure. Copyright © Cambridge University Press 1999 Baugh Claudia L. Stowe Zachary N. CNS Spectrums Cambridge University Press 4/10(1999-10), 34-39 1092-8529 4:10<34 1999 4 CNS https://doi.org/10.1017/S1092852900012347 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1017/S1092852900012347 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Baugh Claudia L. NATIONALLICENCE 700 1- Stowe Zachary N. NATIONALLICENCE 773 0- CNS Spectrums Cambridge University Press 4/10(1999-10), 34-39 1092-8529 4:10<34 1999 4 CNS CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-cambridge